|
AEON Aeon Biopharma Inc 1837607 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-1,155,000.00 |
| Balance Sheet |
|
Current Assets
|
$3,993,000.00 |
|
Assets
|
$5,910,000.00 |
|
Current Liabilities
|
$7,342,000.00 |
|
Liabilities
|
$21,271,000.00 |
|
Equity
|
$-15,361,000.00 |
|
Shares Out
|
26307211.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,334,000.00 |
|
Investing Cash Flow
|
$-4,000.00 |
| Market Analysis |
Market Cap
|
$4,998,370.09 |
|
Price
|
$0.19 |
|
PB
|
1.01 |
|
EPS
|
-0.02 |
|
FCF
|
$-6,338,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:59 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:49 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AEON documents filed with the SEC.
AEON Filings
Clear
